ENTA - Enanta Pharmaceuticals Inc. (ENTA) Q2 2024 Earnings Call Transcript
2024-05-06 20:34:10 ET
Enanta Pharmaceuticals, Inc. (ENTA)
Q2 2024 Earnings Conference Call
May 6, 2024 04:30 PM ET
Company Participants
Jennifer Viera - Investor Relations
Jay Luly - President and Chief Executive Officer
Paul Mellett - Chief Financial Officer
Scott Rottinghaus - Chief Medical Officer
Tara Kieffer - Chief Product Strategy Officer
Conference Call Participants
Eric Joseph - JPMorgan
Roy Buchanan - Citizens JMP
Nik Gasic - Leerink Partners
Jay Olson - Oppenheimer
Presentation
Operator
Good afternoon and welcome to Enanta Pharmaceuticals' Fiscal Second Quarter Financial Results Conference Call. At this time, all participants are on a listen-only mode. There will be a question-and-answer session at the end of the prepared remarks. Please be advised that this call is being recorded.
I would now like to turn the call over to Jennifer Viera, Investor Relations. Please go ahead.
Jennifer Viera
Thank you, operator, and thanks to everyone for joining us this afternoon. The news release with our fiscal second quarter financial results was issued this afternoon and is available on our website.
Making remarks on today's call are Dr. Jay Luly, President and Chief Executive Officer; and Paul Mellett, our Chief Financial Officer. Dr. Scott Rottinghaus, our Chief Medical Officer; and Dr. Tara Kieffer, our Chief Product Strategy Officer will be available during the Q&A portion of this call....
Enanta Pharmaceuticals, Inc. (ENTA) Q2 2024 Earnings Call Transcript